292
Participants
Start Date
March 28, 2025
Primary Completion Date
August 31, 2025
Study Completion Date
August 31, 2026
PRC supported text + AI driven SDH-enhanced text
This interventional study evaluates an AI-driven texting tool combined with peer recovery coach support to deliver social services, reduce stigma, and provide patient navigation content. The goal is to enhance the receipt of buprenorphine in primary care among emergency department-enrolled Black and Latinx individuals who use opioids, addressing the disproportionate impact of opioid overdose deaths on these communities.
AI driven SDH-enhanced text only
This interventional study evaluates an AI-driven SDH-enhanced texting tool to deliver social services, reduce stigma, and provide patient navigation content. The goal is to enhance the receipt of buprenorphine in primary care among emergency department-enrolled Black and Latinx individuals who use opioids, addressing the disproportionate impact of opioid overdose deaths on these communities.
Treatment as Usual (TAU)
Control Arm-3 will receive treatment as usual (i.e., verbal instructions, NYC Dept of Health pamphlets detailing access to OUD and social services, health system smartphone application EMR patient portal).
RECRUITING
NYC Health + Hospitals, The Bronx
Lead Sponsor
Nathan Kline Institute for Psychiatric Research
OTHER
NYU Langone Health
OTHER
Weill Medical College of Cornell University
OTHER
Friends Research Institute, Inc.
OTHER